MedTrace Logo

Progression of Early Subclinical Atherosclerosis

NCT01410318 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4184

Last updated 2021-04-29

No results posted yet for this study

Summary

The overall objective of this study is to characterize the prevalence and progression rate of subclinical atherosclerotic lesions and to study their association to the imaging characteristics of atheroma plaques and to the presence of genetic, epigenetic, metabolomic, and environmental factors, including dietary habits, physical activity, biorhythms, psychosocial characteristics, and exposure to environmental pollutants

Conditions

Sponsors & Collaborators

  • Grupo Santander

    collaborator UNKNOWN

  • Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    lead OTHER

Principal Investigators

  • Valentín Fuster, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Antonio I Fernández Ortiz, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Borja Ibañez, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Ginés Sanz, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Jose María Ordovás, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Luis Jesús Jiménez Borreguero, MD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Jose Luis Peñalvo, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Martín Laclaustra, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Ana Dopazo, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Leticia Fernández Friera, PhD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

  • Agustin Mocoroa, MD · Banco Santander

  • Beatriz Lopez Melgar, MD · Centro Nacional de Investigaciones Cardiovasculares Carlos III

Eligibility

Min Age
40 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-14
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01410318 on ClinicalTrials.gov